These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27365630)

  • 1. MANAGEMENT OF CEREBRAL MALARIA IN THE YEAR 2001.
    Mehta SR; Kashyap AS; Thergaonkar R; Dhaliwal H
    Med J Armed Forces India; 2001 Oct; 57(4):317-9. PubMed ID: 27365630
    [No Abstract]   [Full Text] [Related]  

  • 2. A-5 year review of cerebral malaria in nigerian children.
    Elusiyan JB; Obiajunwa PO; Senbanjo IO; Anyanbolu HC
    Niger Postgrad Med J; 2007 Mar; 14(1):60-2. PubMed ID: 17356594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview: pathophysiology and management of cerebral malaria.
    Looareesuwan S
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():155-65. PubMed ID: 1364863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement.
    Patra S; Singh M; Wasnik K; Pareek D; Gupta PS; Mukherjee S; Paik P
    ACS Appl Bio Mater; 2021 Oct; 4(10):7342-7365. PubMed ID: 35006689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the management of cerebral malaria in adults.
    Mishra SK; Wiese L
    Curr Opin Neurol; 2009 Jun; 22(3):302-7. PubMed ID: 19434799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral malaria -- its management.
    Okelo GB
    Afr J Med Pract; 1994; 1(1):11. PubMed ID: 12287804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax cerebral malaria in an adult patient in Sudan.
    Mukhtar MM; Eisawi OA; Amanfo SA; Elamin EM; Imam ZS; Osman FM; Hamed ME
    Malar J; 2019 Sep; 18(1):316. PubMed ID: 31533821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings.
    Kampfl AW; Birbamer GG; Pfausler BE; Haring HP; Schmutzhard E
    Am J Trop Med Hyg; 1993 Jun; 48(6):818-22. PubMed ID: 8333575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of human cerebral malaria development.
    Wah ST; Hananantachai H; Kerdpin U; Plabplueng C; Prachayasittikul V; Nuchnoi P
    Trop Med Health; 2016; 44():33. PubMed ID: 27708543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody against a ring-infected erythrocyte surface antigen in cerebral and non-cerebral malaria patients.
    Tharavanij S; Tapchaisri P; Mahakunkijcharoen Y; Looareesuwan S
    Trans R Soc Trop Med Hyg; 1988; 82(3):385-8. PubMed ID: 3068852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral malaria in children is associated with long-term cognitive impairment.
    John CC; Bangirana P; Byarugaba J; Opoka RO; Idro R; Jurek AM; Wu B; Boivin MJ
    Pediatrics; 2008 Jul; 122(1):e92-9. PubMed ID: 18541616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of extracellular vesicles and other players in cerebral malaria pathogenesis.
    Debs S; Cohen A; Hosseini-Beheshti E; Chimini G; Hunt NH; Grau GER
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):325-331. PubMed ID: 30339917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Reversible Cerebral Vasoconstriction Syndrome in Cerebral Malaria.
    Yamamoto K; Kato Y; Shinohara K; Kutsuna S; Takeshita N; Hayakawa K; Iwagami M; Kano S; Watanabe S; Ohmagari N
    Am J Trop Med Hyg; 2018 Feb; 98(2):505-507. PubMed ID: 29260652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misdiagnosis of cerebral malaria initially as acute psychotic disorder and later as human rabies: a case report.
    Mudiyanselage MH; Weerasinghe NP; Pathirana K; Dias H
    BMC Res Notes; 2016 Aug; 9(1):400. PubMed ID: 27514689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of children with cerebral malaria in Lagos - a medical audit.
    Lesi FE; Okoromah CN
    Niger Postgrad Med J; 2004 Dec; 11(4):286-9. PubMed ID: 15627158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Toll-like receptor 7 alters cytokine production and protects against experimental cerebral malaria.
    Baccarella A; Huang BW; Fontana MF; Kim CC
    Malar J; 2014 Sep; 13():354. PubMed ID: 25192715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of dual intravenous artesunate plus quinine compared to intravenous artesunate for cerebral malaria in a triple blinded parallel multisite randomized controlled trial in Nigerian children: DUAL PAQ TRIAL Protocol.
    Alao MA; Orimadegun AE; Ibrahim OR; Oyenuga AO; Asinobi AO; Gbadero DA; Okoye IJ; Nna EO
    Trials; 2021 Oct; 22(1):721. PubMed ID: 34670598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria.
    Freeman BD; Martins YC; Akide-Ndunge OB; Bruno FP; Wang H; Tanowitz HB; Spray DC; Desruisseaux MS
    PLoS Pathog; 2016 Mar; 12(3):e1005477. PubMed ID: 27031954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern and predictors of neurological morbidities among childhood cerebral malaria survivors in central Sudan.
    Mergani A; Khamis AH; Fatih Hashim EL; Gumma M; Awadelseed B; Elwali NE; Haboor AB
    J Vector Borne Dis; 2015 Sep; 52(3):239-44. PubMed ID: 26418655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.